Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × ON 01910 × Clear all

NCT00861783 2017-06-23

Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular